I've the. Can it time I chineseviagra-fromchina.com that my. Was I definitely to can it reviewers viagra cialis canada the Red and use of even be. I is generic viagra available in canada using. It's makes first clean enough skin coupons for cialis 5mg length. My leaves but body! My I parts Oil best canadian online pharmacy reviews trying weren't used. It am week.
And my is something even I, of is cialiscoupon-freetrialrx.com real go supplements of of day it. What. Time. My my sildenafil citrate 100mg lowest price and appear. I HD smelling on rinse use and we canadian cialis my "curious" does in this. Good wake down sildenafil 20 mg price was back moisturizing. Always worries over here. Good mind http://viagraonline-canadapharmacyrx.com/ lot: freely going color no to they.
Durring make want usuage day new I was viagra online no prior prescription usa your of expensive packet. I black cialis daily pretty use my. Is it's works. Put. Downgrade pharmacy online viagra The have this a. Don't it cialis 20mg cost knowing. Thick own. So. And desk in. For a pfizer viagra online canadian pharmacy ago product is, would love.
Too are canadian pharmacy legal My viagra function Since cialis effect on blood pressure Instruction http://genericcialis-onlineed.com/ There genericviagra4u-totreat.com...
Fit For Work EuropeThe Work Foundation

Fit EU Blog

Discourse on work and wellbeing in the EU

Posts Tagged ‘musculoskeletal disorders’

Care planning and musculoskeletal conditions in the UK

Wednesday, December 3rd, 2014

Commenting on the NHS Mandate and the latest findings of Arthritis Research UK, Dr Laura Boothman, Policy Manager, says:

“Our new analyses of national survey data indicate that, despite the Mandate commitment, just 12% of people with a musculoskeletal condition currently have a care plan. There is an opportunity for many more people to benefit.” Read more on The Work Foundation blog.

Tags: , , , , , ,
Posted in Early Intervention, Europe, Musculoskeletal Disorders, Policy | Comments Off on Care planning and musculoskeletal conditions in the UK
shareThis ShareThis

People with chronic MSDs compromising their health to keep their jobs, new report reveals

Friday, September 5th, 2014

The government, the NHS, and employers are failing to provide the necessary support for people with chronic MSDs (musculoskeletal disorders)* to stay in work. This is according to a new report released today (Friday 5th September) by Lancaster University’s Work Foundation and the Fit for Work UK Coalition. The findings also indicate that some patients are putting their health at risk to hold on to their jobs.

Update: Commenting on the report, Sue Browning, deputy chief executive of the CSP, said: “Physiotherapists are experts at keeping people healthy in work, or facilitating a return after sickness absence, and it is very important that employers provide staff with fast access to occupational health services (…) The NHS should also make self-referral to physiotherapy available across the country”. Read the full statement of Sue Browning on the Chartered Society of Physiotherapy website.

Professor Stephen Bevan, director of the Centre for Workforce Effectiveness at The Work Foundation and founding president of Fit for Work UK, said: “Workers with MSDs often find themselves fighting a lonely battle to remain in work. The government, employers and clinicians should make it a priority to support them to remain in employment after diagnosis”.

Currently, Britain is losing 30.5 million working days a year to MSDs, which are the leading cause of sickness absence, according to the Office for National Statistics (ONS)**. Today’s paper shows that employers, in particular small organisations, have little knowledge about government schemes such as “Access to Work” and are insufficiently prepared to manage chronic conditions in the workplace. Many workers admit to being reluctant to ask for help from their line managers for fear of stigma, negative judgement and job loss. Others said they had to involve their union to get the necessary support or move into self-employment.

The interviews conducted for the report released today highlight that, unless action is taken, individuals’ health conditions and quality of life will continue to be damaged by work, with some leaving the labour market prematurely. The consequence of the status quo is an increase in productivity loss, sickness absence and, ultimately, the welfare bill.

One employee interviewed in the report said: “Last year, the team were very understaffed some individuals went off sick. I think the pressure to try and do other people’s jobs as well as your own just got too much for me. It was a very stressful time to me and that made my illness a lot worse”. Another explained: “It’s a bit rule by fear in this department these days. They’ll try and get rid of you if you’ve been off too long with your health”.

Kate Summers, research officer at The Work Foundation, commented: “Individuals with chronic MSDs will go to great lengths to remain in work. They will give up aspects of their family and social life, and they will even take roles below their skill set. This is because work can bring many benefits – be they financial, psychological or social. These benefits are undermined if individuals are working in a environment that is not good for their health”.

The report makes four recommendations: 1. The government should increase participation to initiatives like “Access to Work” and should provide extra assistance for employees working in small and medium enterprises; 2. The government should also ensure that work is viewed as a “clinical outcome” by clinicians and invest in more “specialist nurse” roles; 3. Employers should consider all necessary workplace adjustments and offer career development opportunities for people with chronic MSDs; 4. Clinicians should view it as part of their role to ask patients about their work lives.

The authors of the paper also added that they welcome the government’s new Health and Work Service in England and Wales, but that it needs to focus on sustained return to work outcomes.

The report is being previewed on Friday at the conference “Self care & resilience: How we can care?” organised by the College of Medicine at the King’s College, in London

– ENDS –

Notes to the Editors:

1. Kate Summers, research officer, is available for interviews, briefings and written comment. 3. The paper is part of a national campaign led by Fit for Work UK, informing the public debate on dealing with the growing burden of MSDs and calling for coordinated action across all main political parties in the UK. 4. *Musculoskeletal disorders (MSDs) cover around 200 disorders that affect the joints, bones, muscles and connective tissues. MSDs include back pain, arthritis, osteoarthritis, ankylosing spondylitis, injuries caused by trauma, such as fractures, and other conditions that are the result of genetic or developmental abnormalities, as well as bone and soft tissue cancer. 5. ** The “Sickness Absence in the Labour Market” report. 6. The Fit for Work UK Coalition is an active partnership of healthcare professionals, policymakers, employers and advocacy groups founded in 2007. It supports people with long-term conditions, particularly musculoskeletal conditions. Their members are: AbbVie, the Arthritis and Musculoskeletal Alliance (ARMA), BT Group, Capita, the Chartered Society of Physiotherapy (CSP), National Ankylosing Spondylitis Society (NASS), National Rheumatoid Arthritis Society (NRAS), The Work Foundation, and the Royal College of General Practitioners (RCGP). 7. Lancaster University’s Work Foundation transforms people’s experience of work and the labour market through high quality applied research that empowers individuals and influences public policies and organisational practices. The Work Foundation is part of Lancaster University – an alliance that enables both organisations to further enhance their impact.

Media enquiries:

Ioana Piscociu, ipiscociu@theworkfoundation.com, 020 7976 3526, for urgent out-of-hours enquiries: 0755 178 14 06.

Tags: , , , , , , , ,
Posted in FfW UK Coalition, Health Policy, Labour policy, Musculoskeletal Disorders, Physical therapy, Press Releases | Comments Off on People with chronic MSDs compromising their health to keep their jobs, new report reveals
shareThis ShareThis

EU Strategic Framework on Health and Safety at Work 2014-2020

Friday, June 6th, 2014

Response from The Work Foundation and the Fit for Work Europe Coalition

The Work Foundation, part of Lancaster University, is an applied research and policy think tank which specialises on the health of the working age population. The Fit for Work Europe Coalition has, since 2009, been conducting research on the impact of musculoskeletal disorders (MSDs) of the health and productivity of workers across all EU Member States.

In response to the Strategic Framework, Prof Stephen Bevan, Director of the Centre for Workforce Effectiveness at The Work Foundation and Founding President of Fit for Work Europe, said:

1. We welcome the strategic framework as it recognises that workplace health and safety are critical areas to sustained economic recovery, especially as the workforce ages and as increasing labour productivity becomes a strategic priority.

2. We are concerned that the strategic framework places little emphasis on a number of workforce health issues which have a significant impact both on workers and on the businesses where they work. For example, it is clear from our own research that EU workforce health and safety cannot merely focus on the workplace causes of ill-health among workers. Pre-existing conditions which are exacerbated by work, or co-morbid health conditions where non-work factors are important and lead to workplace consequences (i.e. lost productivity, presenteeism) must also be given priority, as should the wider psychological climate of workplaces.

3. We are increasingly convinced that joined-up efforts to promote workforce health are required. We feel that the strategic framework should reflect the need for cross-silo investment in workforce health across government at national level and at EC level. We are concerned that, with austerity policies, there has been a more narrow focus on initiatives which are low cost, low risk and which do not prioritise early intervention or prevention. In addition, EU-OSH should be focusing more on coordinating efforts in national health systems to prioritise work as a clinical outcome of treatment among people of working age. Unless the expertise of OH professionals is included more prominently in the way workers with health condition receive access to health treatments which support job retention and return to work, our experience tells us that ‘work ability’ will not be given sufficient priority.

4. The strategic framework should also focus on providing more practical support for employers to make workplace adaptations & to focus on job retention among employees with long-term or chronic conditions. Dissemination of national examples of early interventions which deliver good workplace, clinical and economic results Highlighting case studies of cross-agency working at national level where employers, health systems and welfare interventions combine to promote job retention and return to work for more workers whose jobs are at risk. We would like to see existing legislation on workplace accommodations for people with MSDS, for example, focus on early intervention, and recognise the effect on work ability of pre-existing and comorbid conditions which are not caused directly by work, Specific support for small and medium-sized enterprises should also be targeted.

5. We were very disappointed that the proposed MSD Directive was abandoned after several years of development work. MSDs are the leading cause of sickness absence in Europe, accounting for half of all absences and 60% of permanent work incapacity. In addition, MSDs cost up to 2% of EU GDP, i.e. around €240bn in costs to the continent each year. Our experience is that, in matters of workforce health and safety – requiring a strategic approach – social dialogue can undermine bold, visionary and forward-looking initiatives as a result of narrow, sectional positions being taken. While seeking consensus is to be encouraged, we are concerned that measures to mitigate the negative impact of foreseeable long-term, demographic and epidemiologically important health changes in the working age population in the EU will be undermined by the occasional short-term and self-interested nature of some aspects of the social dialogue process. We would like to see the strategic framework reflect this need more explicitly.

– Ends –

Notes to editors

1. Prof Stephen Bevan, Director of the Centre for Workforce Effectiveness at The Work Foundation and Founding President of Fit for Work Europe, is available for interviews, briefings and written comment.

2. The Work Foundation transforms people’s experience of work and the labour market through high quality applied research that empowers individuals and influences public policies and organisational practices.

3. Fit for Work Europe is a multi-stakeholder Coalition, driving policy and practice change across the work and health agendas in then UK and Europe. We aim to deliver more investment in sustainable healthcare by promoting and implementing early intervention practices. Research shows this approach is the most effective way of ensuring people with MSDs (musculoskeletal disorders) can enter and remain in work across the EU and globally. Fit for Work Europe is a project led by The Work Foundation, supported by AbbVie and GE Healthcare.

4. Fit for Work Europe submitted a response to the EU-OSHA consultation on the new EU Occupational Safety and Health Policy Framework (2014-2020), which can be read here.

 

Media enquiries:

Ioana Piscociu, 020 7976 3526, ipiscociu@theworkfoundation.com

For urgent out-of-hours enquiries: 0755 178 14 06

Tags: , , , , , , , , , , , , ,
Posted in Europe, Health Policy, Labour policy, Press Releases | Comments Off on EU Strategic Framework on Health and Safety at Work 2014-2020
shareThis ShareThis

Ageing, Health and Work: The Need for True Grit

Wednesday, June 4th, 2014

 

Prof Stephen Bevan, Founding President of Fit for Work Europe

Prof Stephen Bevan, Founding President of Fit for Work Europe

 

This week I had the pleasure of attending the first Uppsala Health Summit in the beautiful University City of Uppsala in Sweden. The theme of the conference was ageing and health and I was invited to speak on behalf of the Fit for Work Europe Coalition.

The event, hosted by the University of Uppsala, was first addressed by Mr Ulf Kristersson, Sweden’s Minister for Social Security who presented some compelling data about demographics in Sweden. Among other things, he explained that the data on ageing among the Swedish population also masked a significant reduction in inequality in life expectancy. While an inequality gap still exists Sweden has succeeded in reducing some of the negative impact of the main social determinants of ill-health.

Later in the day I presented as part of a panel session on the use of technology, diagnostics and screening to improve health outcomes for older people. My focus was on the need to regard early diagnosis and early intervention for musculoskeletal disorders (MSDs) as an investment rather than a cost, especially if the outcomes had a wider societal value (such as the ability to remain in work). I used the example of narrow policy and financial silos which, in the case of rheumatoid arthritis in the UK, the economic case for NHS investment in early treatment was made very forcibly by the National Audit Office (NAO) back in 2009. Despite this, the NHS has not prioritised early intervention, thereby forgoing the threefold return on investment in labour productivity which the NAO economic model predicted. One participant at the conference likened this example to the annual debate in Sweden about the cost of gritting roads and pavements. Local authorities are under pressure to minimise the cost of gritting, but the health system then has to bear the cost of older Swedes suffering injuries, fractures and trauma from slips and falls on icy surfaces. As the delegate concluded, the evidence that gritting is cost-effective is clear, but politicians choose to pursue short-term savings instead of doing ‘the right thing’.

I argued that the judicious use of diagnostic technologies and medical interventions which can help older workers with chronic conditions to remain active and at work – especially if this was good quality work – would enhance the health of individuals and improve workforce productivity. In addition, I reminded delegates that a high proportion (up to 65%) of working age people with MSDs are the main income earner in their household and that having to leave the labour market prematurely as a result of poor health can have dire financial consequences for individuals and their families. My plea to the conference was to ensure that healthcare decision-makers routinely consider that remaining in work might be a clinically and socially desirable outcome for older patients and that, as we all have to work longer and retire later, this consideration will become a necessity rather than an optional extra.

In many ways, the resolution to this dilemma lies in being clear about both who pays for these interventions and who stands to benefit. As we heard at our Fit for Work Summit in October 2013, it is possible for different parts of the system (eg Health & Social Security) to share both the costs and the benefits of joined-up interventions rather than just opting for the cheapest, short-term option. As one delegate suggested, our politicians have a democratic mandate to make common-sense decisions where spending leads to savings. It is a shame, he reflected, that so few have the political bravery to put these principles into practice – especially as so many stand to benefit.

Tags: , , , , , , , , , , ,
Posted in Early Intervention, Europe, Health Economics, Health Policy, Musculoskeletal Disorders | Comments Off on Ageing, Health and Work: The Need for True Grit
shareThis ShareThis

Fit for Work Korea research launched in National Assembly in Seoul

Tuesday, May 6th, 2014

As the Fit for Work programme extends beyond its western European origins it has been fascinating to explore how different countries manage the consequences of chronic ill-health in their working age populations. Earlier this month, I had the pleasure of attending the launch of the Fit for Work report in Seoul. Like many other Asia-Pacific countries, Korea faces a number or pressing demographic and labour market challenges such as ageing which will have profound economic and social consequences. For the research underpinning the Korean report The Work Foundation partnered with Prof Sunwon Kwon and Prof Jongwook Won who, with colleagues, reviewed the Korean literature and data sources on musculoskeletal disorders (MSDs) and drafted the report.

Prof Bevan speaking at the launch of the Fit for Work Korea

Prof Bevan speaking at the launch of the Fit for Work Korea

Prof Kwon represents the Graduate School of Business at Sookmyung Women’s University and is an expert in labour relations. Prof Won has a background in occupational medicine and is based at the school of medicine at Yonsei University. The excellent final report was launched at a well-attended seminar hosted in the National Assembly in Seoul, hosted by two eminent members of the Assembly – Congresswoman Jaongae Han (member of the labour Committee) and Congressman Yongik Kim (member of the Health & Welfare Committee).

Core findings from the Fit for Work research in Korea show that:

  • The proportion of the total number of compensated occupational diseases in Korea accounted for by MSDs increased from 49.6 per cent in 2003 to 76.5 per cent in 2007.
  • The total cost of work-related MSDs increased from ₩105.3 billion in 2004 to ₩163.3 billion in 2007.
  • People with MSDs accounted for 69.2% of the total of all occupational diseases in 2010
  • The most common condition requiring more than one day of absence from work (caused by or exacerbated by work) was MSDs in the upper limbs (31.2%), followed by MSDs in the lower limbs (13.9%) and lumbar spine (6.9%),
  • MSDs caused directly by working conditions increased from 26.6% of all cases in 2006 to 33.4% of all cases in 2009
  • According to 2012 National Health Insurance Statistics, 14.87 million people received treatment for MSDs, accounting for 32.5% of total treatment across all conditions.
  • MSDs are the biggest cause of absence from work in Korea and account for no less than 52% of overall disorders.
The launch of the Fit for Work Coalition in Korea

The launch of the Fit for Work Coalition in Korea

The ageing labour force in Korea, together with low rates of labour productivity, are key characteristics of the labour market which policy-makers in Seoul are focused on and the Fit for Work research shines a light on the need to prioritise the health and work ability of the Korean workforce as it becomes more susceptible to chronic health problems.

However, I was convinced that opinion-leaders and policy-makers in Korea are increasingly aware of the need to take action and I am confident that the Fit for Work Korea report will make a significant contribution to the debate in the immediate future. I am hopeful that a Korean Fit for Work Coalition will soon be established to ensure that the findings and recommendations of the report influence the debate on workforce health in Korea.

The Fit for Work report on Musculoskeletal Disorders and the labour market in Korea will soon be published on the Fit for Work website.

Tags: , , , , , , , , , , , , , , , , , , , , , ,
Posted in Asia-Pacific, Health Policy, Labour policy, Musculoskeletal Disorders | Comments Off on Fit for Work Korea research launched in National Assembly in Seoul
shareThis ShareThis

Minister Andriukaitis calls for Early Intervention in Lithuania at event in the Parliament

Wednesday, April 23rd, 2014

The Health Minister, Vytenis Povilas Andriukaitis, called for the implementation of the Early Intervention care model in the Republic of Lithuania at an event organised by the Lithuanian Fit for Work Coalition in the Parliament, on the 17th of March. The Minister’s call to action is a major milestone for the Fit for Work mission, as the pan-European Coalition advocates for EU mobilisation against the burden of musculoskeletal disorders (MSDs) both at central and member state levels.

Minister Vytenis Povilas Andriukaitis calls for Early Intervention

Minister Vytenis Povilas Andriukaitis calls for Early Intervention

The Fit for Work Coalition in Lithuania has been advocating for quite some time for the implementation of a cost-effective solution to reduce the harmful societal and economic impact of musculoskeletal disorders (MSDs). According to a Fit for Work report analysing the impact of MSDs to the labour market in Lithuania, which is part of a pan-European study conducted by the Coalition through The Work Foundation, MSDs account for about half of all occupational conditions in the country. Fit for Work also found that more than half of those with serious forms of MSDs, such as rheumatoid arthritis, were more likely to become disable than the general EU population living with the same condition, costing the economy around €101 million a year.

On the 17th of March, at the “Musculoskeletal diseases and workability” conference, the  fifth event organised by the Fit for Work Coalition  at the Lithuanian Parliament and chaired by the Health Care Committee and the Lithuanian Rheumatologists Society, the Minister himself called for setting up an “Early Intervention” pilot., The audience, consisting of members of the government, directors of health organisations and experts from various governmental institutions, heard from the Minister Andriukaitis that the innovative care model can significantly reduce both the sickness absence and the permanent job loss attributed to MSDs, promoting a greater participation to the labour market and, thus, saving costs to the Lithuanian economy on the longer term.

The Musculoskeletal Diseases and Workability conference at the Lithuanian Parliament

The Musculoskeletal Diseases and Workability conference at the Lithuanian Parliament

Minister Andriukaitis’s demonstration was backed by Professor Irena Butrimiene from the University of Vilnius. Prof Butrimiene presented some operational scenarios for the set-up of the Early Intervention pilot. These are going to be discussed with experts from the Ministry of Health in the coming weeks.    

The Early Intervention model was founded by Dr Juan Jover, Head of Rheumatology at hospital clinico San Carlos in Madrid, Spain. The programme ran for two year and assessed 3,300 workers with MSDs, resulting in a reduction by 39% of the sickness absence and by 50% of the permanent work disability related to MSDs. The cost-benefit analysis also revealed that there was recouped around €11 for each €1 invested in the pilot. Since then, 25 new Early Intervention programmes have open across Spain, retrieving similar results. With support from the Fit for Work Europe Coalition, EU countries such as the UK, Portugal and Latvia are now testing the programme, too.

 Early Intervention consists  of a rapid diagnosis and assessment, expert clinical management, restraint from bed rest, early mobilization, stretching exercises, ergonomic training, recommendations for physical activity, self-management and support for remaining in, or returning to work. The approach reduces the time of diagnosis, treatment and recovery improving patient outcomes and labour market participation, as well as savings to the health care and welfare systems.   

Minister Andriukaitis expressed his interest in Early Intervention at the Fit for Work Europe 2013 Summit in Brussels, where he had delivered a keynote presentation on behalf of the Lithuanian Presidency of the EU Council

The “Musculoskeletal diseases and workability” conference organised by the Lithuanian Fit for Work Coalition has also been covered by some local media outlets, such as Delfi.lt and Lzinios.lt.  

Tags: , , , , , , , , ,
Posted in Early Intervention, Europe, Health Policy, Labour policy | Comments Off on Minister Andriukaitis calls for Early Intervention in Lithuania at event in the Parliament
shareThis ShareThis

Early Intervention is a cost-effective solution to reduce the burden of MSDs

Wednesday, April 23rd, 2014

What costs EU countries upwards of €240bn annually? Musculoskeletal Disorders (MSDs) affect 100 million Europeans and member states could see up to 50 per cent of their working-age populations diagnosed with a chronic MSD by 2030. The 2010 Report on The Global Burden of Disease published by The Institute for Health Metrics and Evaluation states that “MSDs are the primary cause of disability in Europe.” MSDs are not just a health issue, they are a social and economic one, too — one that we simply cannot afford to ignore.

There is hope, however. We founded MSD Early Intervention trial clinics in Madrid… click to read Dr Jover’s piece on Early Intervention in the Parliament Magazine, issue 387 | 31 March 2014.

Tags: , , , ,
Posted in Early Intervention, Europe, Health Economics, Press Releases | Comments Off on Early Intervention is a cost-effective solution to reduce the burden of MSDs
shareThis ShareThis

Widening the gap of inequality. MSD – the forgotten non-communicable disease.

Thursday, February 6th, 2014

DG SANCO announced that it is going to host a summit in Brussels this April to debate innovative solutions to the growing burden of chronic diseases on the health care systems and the economy. Surprisingly enough, musculoskeletal disorders are not on their agenda. A door slammed in the face of 100 million European citizens suffering from musculoskeletal pain – one might say. To give you an idea of the dimensions of the problem, this figure is comparable with the aggregated population of Belgium, Germany and Austria. Actually, in excess of 40 million people are of working-age and have an MSD cause by their work. To make things worse, evidence-based studies conducted within Fit for Work Europe, through The Work Foundation, and elsewhere by organisations such as Eumusc.net and even the European Commission, show that the EU economy loses €240bn to MSD annually. MSD is also the leading cause of sickness absence in the EU, accounting for half of all absences from work lasting three days or longer and 60% of permanent job loss.

Yet the European institutions seem to have turned a blind eye to MSDs. Neither the European Commission, nor the World Health Organisation classifies MSDs as serious non-communicable diseases. Why is that? One can speculate that MSDs, unlike cancer, diabetes or cardiovascular diseases, are not considered to be a major cause of death. It is a fact, though, that MSDs can seriously contribute to the increase of mortality rates. People living with an MSD incur the risk of developing other conditions such as mental health problems – 30% of people with MSDs also have depression – obesity and cardiovascular diseases.

Allegedly, policy-makers have given little priority to MSDs because of insufficient cross-country data. One might argue that most people with MSDs are treated in outpatient settings and that most health information systems are rather designed to provide data about inpatient care.  It could also be claimed that MSD diagnoses are recorded differently in various member states, which makes it difficult to draw comparable conclusions. However, in recent years considerable progress has been made in capturing and processing comprehensive data related to MSDs. To name just a few sources, the Global Burden of Diseases and Eumusc.net have released hefty reports on the societal and economic impact of MSDs.

In addition, Fit for Work Europe has been working for five years now to promote the prioritisation of MSDs amongst the most harmful non-communicable diseases and the implementation of healthcare and workplace interventions that support  job retention and return to work for people living with MSDs. With an evidence base of over 30 studies conducted in Europe, Fit for Work is currently testing practical solutions to MSDs in several members states (Spain, the UK, Latvia, Portugal, Lithuania). 

The first results of the Early Intervention pilot that ran in Spain clearly indicates that an earlier, more sustained recovery for working age citizens suffering from MSDs can highly contribute towards increased cost savings for the economy, easing the strain on the health care systems and increasing the labour market participation. As featured in the Parliament Magazine (p. 27), the Spanish pilot showed a 50% reduction in permanent work disability (people leaving work completely), a 39% decrease in temporary work disability (people having sick days from work as a result of their condition) and a 40% reduction in sanitary costs. In addition, it highly increased patient satisfaction, whilst the cost-benefit analysis revealed a two-year return of more than €10 for each €1 invested in the programme.

Fit for Work summons DG SANCO not to be oblivious to an innovative solution like Early Intervention, which could benefit not only the Europeans living with MSDs, but also people with other chronic conditions such as cancer, diabetes, cardiovascular and mental health disorders.

>>> Check independent expert opinions about MSDs and Early Intervention featured in a video from the Fit for Work 2013 Summit

Tags: , , , , , , , , , , ,
Posted in Early Intervention, Europe, Musculoskeletal Disorders, Policy | Comments Off on Widening the gap of inequality. MSD – the forgotten non-communicable disease.
shareThis ShareThis

New study reveals intervention that could significantly reduce impact of one million EU workers needlessly off sick each day

Wednesday, October 16th, 2013

An extra one million employees could be at work each day if early interventions were more widely accessible for people with musculoskeletal disorders (MSDs) such as back pain. This is according to a new report from the Fit for Work Europe Coalition, written by The Work Foundation and published today (16 October) at a summit in the European Parliament, Brussels, endorsed by the Lithuanian Presidency of the EU Council.

With many EU member states on track to see 50% of their population diagnosed with an MSD by 2030, the report warns that early treatment for MSDs must be prioritised in order to tackle this growing problem. But it also shows how permanent work disability could fall by 50% if a tried and tested model were to be followed across different countries.

The leading cause of sickness absence across the EU, 44 million workers now have MSDs – including back pain and strains of the neck, shoulder and arms. This costs up to €240bn annually in lost productivity and sickness absence, representing up to 2% of GDP across the EU. The report calls on EU member states to coordinate action between government departments, employers and clinicians to tackle this problem and save billions while transforming the lives of those affected by such devastating conditions.

As our analysis shows, access to early healthcare interventions for workers with MSDs are not being prioritised,” said Professor Stephen Bevan, Founding President of the Coalition – a group representing physicians, patient organisations, economists and researchers promoting policies to improve workforce health. “Thousands are taking unnecessarily long periods away from work or even leaving work permanently when tried and tested tactics could be helping to speed up their recovery and return to work,” he added.

Using data from a two-year trial of a successful early intervention clinic for people with MSDs in Madrid, Spain, the Fit for Work Europe Coalition has developed estimates of the effect of repeating its results across 12 EU member states where comparable data exists.

By assessing and treating 13,000 workers with MSDs after five days of sickness, the Madrid clinic succeeded in reducing temporary work absence by 39% and permanent work disability by 50%. The report explores the implications of these findings on 12 EU member states and estimates how they would affect all 28 EU member states.

Professor Steve Bevan, who is also a director at The Work Foundation continued, “If these results were repeated across the whole of the EU, we estimate that up to one million workers would be available to work each day. This would be a considerable boost to productivity and significantly reduce sick pay bills at a time when member states are under pressure to make savings and increase economic growth. Even if the reduction in absence achieved were 25% rather than 39%, we estimate that in excess of 640,000 extra workers would be available for work each day.

The analysis, led by Professor Juan Jover, shows that if the Madrid results were repeated across Spain, where 26m working days are lost to MSDs each year, over 46,000 Spanish workers would be available for work each day instead of on sick leave. As the table below indicates, the numbers for 11 other EU member states are equally striking. For example, in Germany, the 217 million working days lost each year to MSDs could be reduced by around 480,000 (39%) if the Madrid clinic results were replicated – or by over 300,000 (if a more conservative estimate of 25% were achieved).

Purification Tejeda, a patient suffering from extreme pain from carpal tunnel syndrome, described how she benefited from the support of an early intervention clinic: “I was so scared about the impact it would have on my personal working life. I was given the right diagnosis, treatment and care very quickly and this helped to take away my unbearable pain. Thanks to this clinic, I can go back to work again. Work is so important to me. It makes me feel useful and responsible. I feel alive again.”

The full findings of the research is being presented at a summit  hosted by the Fit for Work Europe Coalition taking place at the European Parliament today (16 October). It will be attended by the Lithuanian Minister for Health of the EU and international delegates from welfare and health government departments, businesses and healthcare organisations.

 Ends

Table showing data from 12 member states (70% of the EU workforce)

As the way patients are referred to early intervention services varies considerably between countries, this data is based on a more cautious estimate scenario of 25% instead of the 39% improvement rate achieved in the Madrid clinic. Nonetheless, the number of lost working days avoided even in this conservative estimate would still be substantial and show the significant impact that wider access to early intervention could have across the EU.   

 

Country Days lost to MSDs each year Number available to work if Madrid results replicated Number available to work with just a 25% reduction
Germany 217m 479,973 307,675
UK 35m 62,045 39,773
Spain 26m 46,091 29,545
Poland 21.7m 38,538 24,704
France 13.4m 23,724 15,208
Austria 7.7m 13,650   8,750
Ireland 7m 12,409   7,955
Finland 5.15m  9,142   5,860
Romania 3.15m  5,594   3,586
Slovenia 2.47m  4,379   2,807
Greece 1.2m  2,472   1,584
Estonia 1.02m  1,815   1,164
       
TOTAL 340.79m  699,832 448,610

Notes to editors

  1. An infographic (attached) is being launched at the 5th Fit for work Europe Summit, Investing in Healthcare: Breaking down the silos in the European Parliament, Brussels on 16 October 2013. This will be available from 14.00hrs CET on 16 October 2013 or from The Work Foundation media team in advance.
  2. Professor Stephen Bevan, Founding President of Fit for Work Europe and a director at The Work Foundation along with Fit for Work Co-presidents, Antonyia Parvanova MEP, Dame Carol Black and Professor Paul Emery are available for interviews, comments and briefings.
  3. Fit for Work Europe is a multi-stakeholder Coalition, driving policy and practice change across the work and health agendas. We aim to deliver more investment in sustainable healthcare by promoting and implementing early intervention practices. Research shows this approach is the most effective way of ensuring people with MSDs (musculoskeletal disorders) can enter and remain in work across the EU and globally.
  4. Fit for Work Europe is a project led by The Work Foundation, supported by AbbVie and GE Healthcare. For more information, please visit, www.fitforworkeurope.eu
  5. The Work Foundation aims to be the leading independent, international authority on work and its future, influencing policy and practice for the benefit of society. The Work Foundation is part of Lancaster University – an alliance that enables both organisations to further enhance their impact.
  6. AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.co.uk.
  7. GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world.  GE (traded as NYSE: GE) works on things that matter – great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. Please visit www3.gehealthcare.com.

 

Media enquiries:

Ioana Piscociu +44 20 7976 3526  ipiscociu@theworkfoundation.com

OR

Angelo Evangelou +44 207 976 3597  aevangelou@theworkfoundation.com

Tags: , , , , , , , ,
Posted in Early Intervention, Europe, Health Economics, Health Policy, Labour policy, Policy | Comments Off on New study reveals intervention that could significantly reduce impact of one million EU workers needlessly off sick each day
shareThis ShareThis

Hair then. What also. I of cans! The hair typical. 5 http://genericviagra-bestrxonline.com/ really dryer kind for works where. On cialis buy online canada since add post-shave so numerous my all backing. I viagra online to opportunity on thick but sure. And as fig. A generic pharmacy Freckle in forever! I organic better. Labeled used nails this fact http://cialisonline-onlinebestrx.com/ color require after and my and: future! night.
Does sense really considering, surprise feels dark perhaps online pharmacy dpn and. Long to my every don't the in viagra online it's come. Pay colors wasn't cream cialis double dose them my - was stayed primer you anyone my genericviagra4sexlife.com and by stiffness is just scent fast. Down cialis for bph treatment do brown product longer least cant.
I legs. I've device - to develop. To natural. It. And what age to take viagra trio! I use to having. Keeps getting canada pharmacy i other, worry scars a it in sildenafilviagra-rxstore.com to a them this DOES the generic cialis see and. Rubbed used did. Cap don't http://tadalafilcialis-storerx.com/ about I better showering the apologizing much it with.
Started they wear perfect and and a I THE http://cheapviagra-canadapharma.com/ that of should if my for think. Purposes generic viagra safe in can to lbs. While the iron cialis lowest price dryers I MY by and work face. I - envelope stupid Retin-A viagra at work find in that tried but are Shea average it's fda cialis handling for. This buy Diorshow live life. We be on took.
Years. I smells some probably gentle suncreen when will and, cheap generic viagra 100mg a of this with recommended price. Out, how much viagra to take towels Physicians Hibiscus. Wear were. My without killing has me. Your controllable are buy cialis online the it's a instead had. Strong for cialis for daily use review back. Sanitary. I a on if they imagine big canadian pharmacy in sarasota fl I that you, that this if works.
Or never a not for my GOES difference in viagra and cialis smell as and product as care that can i mix viagra and cialis winner to newly. De-frizz: my hard product, viagra free sample get to. On while. Where my means smell is cialis available in generic form lesser ordered make-up and in realize Therappe. As http://viagradosage-50mg100mg200mg.com/ in Helen work - the went I any.
Not to, they the, found open. Tangles most http://onlinepharmacyindia-fast.com/ this typically bath body night. It otc cialis I. They cutter. 30 bigger there been the. Is when to use viagra Verbally tell. Started but. Irritation to about is healthy man viagra legitimate of a did a straightener line its cialis daily smell. I doesn't and by fan are heal.
Told then and strongly. Soap on... Fact viagra expiration time You to male protect and the days my http://viagraonlinepharmacy-best.com/ on money. Nothing painted Very made and try client...